Vanda Pharmaceuticals Inc (VNDA) — Cash Flow Reinvestment Rate

Latest as of March 2024: 2.41x

Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow Reinvestment Rate of 2.41x as of March 2024, reinvesting $18.23 Million (capex $7.00K plus investments $-18.22 Million) from operating cash flow of $7.57 Million. Explore how much does Vanda Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.41x
(Capex + Investments) / Operating CF

Total Reinvested

$18.23 Million
Capex + Investments

Operating Cash Flow

$7.57 Million
USD

Capital Expenditures

$7.00K
USD

Vanda Pharmaceuticals Inc Cash Flow Reinvestment Rate (2009–2023)

Historical reinvestment intensity for Vanda Pharmaceuticals Inc across 8 annual periods. Also explore VNDA current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Vanda Pharmaceuticals Inc (2009–2023)

Year-by-year capital reinvestment analysis for Vanda Pharmaceuticals Inc. For live market cap and broader valuation context, see VNDA market cap overview.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2023 8.40x $107.54 Million $12.80 Million $383.00K ▲ +423.9%
2022 1.60x $51.28 Million $31.98 Million $679.00K ▲ +34.2%
2021 1.19x $76.70 Million $64.21 Million $552.00K ▲ +49.0%
2020 0.80x $41.50 Million $51.77 Million $1.79 Million ▼ -46.1%
2019 1.49x $68.31 Million $45.95 Million $1.02 Million ▼ -59.3%
2018 3.66x $109.66 Million $29.99 Million $25.37 Million ▲ +71.2%
2015 2.14x $26.60 Million $12.45 Million $2.53 Million ▲ +2915.0%
2009 0.07x $12.00 Million $169.34 Million $12.00 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow